Burn Injury Clinical Trial
Official title:
Effects of Extracorporeal Shock Wave Therapy in Cutaneous Microcirculation of Different Wounds
NCT number | NCT02417779 |
Other study ID # | 14-266-1 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2015 |
Est. completion date | February 2023 |
Verified date | February 2023 |
Source | University Hospital Schleswig-Holstein |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In plastic and reconstructive surgery, treatment strategies of second-degree burns, superficial wounds, hypertrophic burn scars, flaps and chronic wounds aim at reducing infection and improving microcirculation. Although previous studies indicate that extracorporeal shock wave therapy (ESWT) can accelerate wound healing, only a few studies focused on the elucidation of its mechanisms of action. Therefore, the aim of this study is to evaluate the microcirculatory effects of extracorporeal shock wave therapy on second-degree burns, superficial wounds, hypertrophic burn scars, flaps and chronic wounds in a human in-vivo setting for the first time.
Status | Completed |
Enrollment | 240 |
Est. completion date | February 2023 |
Est. primary completion date | February 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Group A (n=20): Consent-capable male and female patients =18 years of age who have sustained a second-degree burn on =1% and =30% of the surface of the body. - Group B (n=20): Consent-capable male and female patients =18 years of age who require a skin excision for the purpose of a skin graft. The minimal size of the skin-graft donor site must not be less than 1% of TBSA. - Group C (n=20): Consent-capable male and female patients =18 years of age suffering from a wound that has not yet healed =3 weeks. The minimal size of the wound site must not be less than 1% of TBSA. - Group D (n=20): Consent-capable healthy male and female probands =18 years of age serving as sham group. None of the the criteria of groups A-C must be evident. No soft tissue injury must be evident. - Group E (n=20): Consent-capable male and female patients =18 years of age who have sustained a second-degree burn on =1% and =30% of the surface of the body. - Group F (n=20): Consent-capable male and female patients =18 years of age who require a skin excision for the purpose of a skin graft. The minimal size of the skin-graft donor site must not be less than 1% of TBSA. - Group G (n=20): Consent-capable male and female patients =18 years of age suffering from a wound that has not yet healed =3 weeks. The minimal size of the wound site must not be less than 1% of TBSA. - Group H (n=20): Consent-capable healthy male and female probands =18 years of age serving as sham group. None of the the criteria of groups E-G must be evident. No soft tissue injury must be evident. - Group I (n=20): Consent-capable male and female patients =18 years of age suffering from a hypertrophic burn scar. - Group J (n=20): Consent-capable male and female patients =18 years of age suffering from a hypertrophic burn scar. - Group K (n=20): Consent-capable male and female patients =18 years of age who received a flap. - Group L (n=20): Consent-capable male and female patients =18 years of age who received a flap.. Exclusion Criteria: General exclusion criteria - below 18 years of age - wounds requiring artificial respiration, since consent for the study participation is unobtainable Exclusion Criteria Groups A, B, D, E, F, H: - peripheral arterial occlusive disease - vasculitis - diabetes mellitus - chronic kidney or liver disease - cardiac dysfunction - arterial hypo- or hypertension Anamnestic exclusion criteria - ongoing immunosuppressive or chemotherapy treatment - drug abuse - systemic skin diseases - systemic and local cortisone therapy |
Country | Name | City | State |
---|---|---|---|
Germany | University of Schleswig-Holstein | Lübeck | Schleswig-Holstein |
Lead Sponsor | Collaborator |
---|---|
University Hospital Schleswig-Holstein |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in microcirculation (composite measure) | capillary blood flow [arbitrary units AU]
capillary blood velocity [AU] tissue oxygen saturation [%] relative postcapillary venous filling pressure [AU] |
Baseline and 1 minute post-dose | |
Secondary | Change in microcirculation (areolar measure) | tissue oxygen saturation [%]
tissue hemoglobin index |
Baseline, while and 1 minute post-dose |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02241941 -
Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury
|
Phase 4 | |
Completed |
NCT02210208 -
A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.
|
N/A | |
Completed |
NCT05063409 -
Transfusion Ratio of Fresh Frozen Plasma (FFP) to Packed Red Blood Cell (PRBC) During Burn Excision and Grafting
|
N/A | |
Completed |
NCT03730688 -
Non-invasive Limb Compartment Pressure Measurement
|
N/A | |
Recruiting |
NCT04368117 -
STAT: Standard Therapy Plus Active Therapy
|
N/A | |
Terminated |
NCT01773083 -
Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
|
Phase 3 | |
Completed |
NCT02092701 -
Effects of Cholecalciferol Supplementation on Bone Health and Muscle Strength in Adults During Post-burn Period
|
N/A | |
Recruiting |
NCT06263296 -
Smartphone Assisted Self-management Education for Adult Burn Patient at Aftercare
|
N/A | |
Completed |
NCT02145130 -
Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
|
Phase 1 | |
Completed |
NCT01618630 -
Amino Acid Supplementation in Recovery From Severe Burns
|
N/A | |
Recruiting |
NCT05876442 -
Efficacy of EPSW Plus HILT on Carpal Tunnel Syndrome Post Burn Injury
|
N/A | |
Completed |
NCT04417439 -
The Effect of Acute Phase Treatment Approaches on Creatine Kinase and the Musculoskeletal System in Different Types of Burns
|
||
Completed |
NCT02417805 -
Cutaneous Microcirculation After Remote Ischemic Preconditioning
|
N/A | |
Completed |
NCT02417818 -
Cutaneous Microcirculation After Plasma Therapy
|
N/A | |
Completed |
NCT01404026 -
Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury
|
N/A | |
Completed |
NCT03204669 -
Trace Element Repletion Following Severe Burn Injury
|
N/A | |
Recruiting |
NCT04947449 -
Potential Benefits of Laser Treatment on Skin Blood Flow and Sweating in Burn Survivors
|
||
Not yet recruiting |
NCT05532488 -
Inulin in Burn-induced Insulin Resistance
|
N/A | |
Recruiting |
NCT02189538 -
Effect of n-3 PUFA From Fish in Enteral Nutrition of Major Burn Patients
|
N/A | |
Completed |
NCT01795079 -
Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury
|
N/A |